CIK: 0001807489 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 10, 2022
Total Value ($000): $95,792 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IVVD | INVIVYD INC | 9,248,250 | $28,947 | 30.2% | $17.64 | -77.4% | COM | 00534A102 |
| WVE | WAVE LIFE SCIENCES LTD | 7,982,204 | $28,816 | 30.1% | $3.07 | +7.9% | SHS | Y95308105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 665,880 | $10,627 | 11.1% | $24.20 | -35.5% | COM | 77313F106 |
| STOK | STOKE THERAPEUTICS INC | 522,550 | $6,710 | 7.0% | $23.86 | -33.2% | COM | 86150R107 |
| BBIO | BRIDGEBIO PHARMA INC | 513,300 | $5,102 | 5.3% | $39.38 | -73.6% | COM | 10806X102 |
| — | MIRATI THERAPEUTICS INC | 61,200 | $4,274 | 4.5% | $97.15 | — | COM | 60468T105 |
| — | CURIS INC | 4,482,142 | $3,137 | 3.3% | $3.68 | — | COM NEW | 231269200 |
| — | VERVE THERAPEUTICS INC | 87,600 | $3,009 | 3.1% | $22.82 | — | COM | 92539P101 |
| — | LEAP THERAPEUTICS INC | 2,664,400 | $2,345 | 2.4% | $2.31 | — | COM | 52187K101 |
| TGTX | TG THERAPEUTICS INC | 338,800 | $2,006 | 2.1% | $18.81 | -65.1% | COM | 88322Q108 |
| PRQR | PROQR THRAPEUTICS N V | 1,001,800 | $745 | 0.8% | $3.35 | -76.0% | SHS EURO | N71542109 |
| — | NEXIMMUNE INC | 133,442 | $74 | 0.1% | $4.61 | — | COM | 65344D109 |